学术成果

　　1、周世杰,郝学峰,于大平,刘树库,曹小庆,苏崇玉,宋小运,肖宁,李云松,杨威,赵丹,王敬慧,刘志东,许绍发.新辅助免疫治疗联合化疗在可手术的非小细胞肺癌的初步疗效评估[J].中国肺癌杂志,2021,24(06):420-425.

　　2、Cheng X, Ma T, Yi L, et al. Low expression of BTN3A3 indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer. Ann Transl Med. 2021;9(6):478.

　　3、王宇轩,苏崇玉,刘志东.Alu-qPCR检测游离DNA长度在肺结节良恶性鉴别中的应用[J].现代肿瘤医学,2021,29(06):944-949.

　　4、曹小庆,刘志东,于大平,韩毅.胸腔镜和开胸肺叶切除术对非小细胞肺癌患者免疫因子、炎性因子表达水平影响的研究[J].中国医刊,2020,55(12):1358-1361.

　　5、Chai Q, Lu Z, Liu Z, et al. Lung gene expression signatures suggest pathogenic links and molecular markers for pulmonary tuberculosis, adenocarcinoma and sarcoidosis. Commun Biol. 2020;3(1):604. Published 2020 Oct 23.

　　6、马廷龙,韩毅,程序,刘志东.超声抗结核药品电导入联合化疗对胸壁结核的疗效观察[J].中国防痨杂志,2020,42(09):968-972.

　　7、Li Z, Li C, Bao R, Liu Z. Expressions of miR-29a, TNF-Α and Vascular Endothelial Growth Factor in Peripheral Blood of Pulmonary Tuberculosis Patients and Their Clinical Significance. Iran J Public Health. 2020;49(9):1683-1691.

　　8、Zhu N, Wang W, Liu Z, et al. Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells. Nat Commun. 2020;11(1):3910. Published 2020 Aug 6.

　　9、Shi JQ, Wang B, Cao XQ, et al. Circular RNA_LARP4 inhibits the progression of non-small-cell lung cancer by regulating the expression of SMAD7. Eur Rev Med Pharmacol Sci. 2020;24(4):1863-1869.

　　10、Yu D, Liu Z, Su C, et al. Copy number variation in plasma as a tool for lung cancer prediction using Extreme Gradient Boosting (XGBoost) classifier. Thorac Cancer. 2020;11(1):95-102.

　　11、Li YF, Gao Y, Liang BW, et al. Patient-derived organoids of non-small cells lung cancer and their application for drug screening. Neoplasma. 2020;67(2):430-437.

　　12、文韬,韩毅,周世杰,刘志东.血浆游离DNA中黑色素瘤抗原A1基因启动子区甲基化在非小细胞肺癌诊断中的临床应用[J].中国医刊,2019,54(06):635-639.

　　13、Zhang Q, Nong J, Wang J, et al. Isolation of circulating tumor cells and detection of EGFR mutations in patients with non-small-cell lung cancer. Oncol Lett. 2019;17(4):3799-3807.

　　14、Xu ST, Xi JJ, Zhong WZ, et al. The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104). J Thorac Oncol. 2019;14(3):503-512. doi:10.1016/j.jtho.2018.11.020

　　15、Yu D, Liu Z, Su C, et al. Copy number variation in plasma as a tool for lung cancer prediction using Extreme Gradient Boosting (XGBoost) classifier. Thorac Cancer. 2020;11(1):95-102.

　　16、Duan X, Zhu Y, Cui Y, et al. Circulating tumor cells in the pulmonary vein increase significantly after lobectomy: A prospective observational study. Thorac Cancer. 2019;10(2):163-169.

　　17、Han Y, Xiao N, Huang S, Qin M, Che N, Liu Z. The Application of Xpert Mycobacterium tuberculosis/Rifampicin, Quantitative Polymerase Chain Reaction and High Resolution Melting Curve in the Diagnosis of Superficial Lymph Node TB. Curr Pharm Biotechnol. 2019;20(12):1044-1054.

　　18、Zhang TX, Zhang Y, Liu ZD, Zhou SJ, Xu SF. The volume threshold of 300 versus 100 ml/day for chest tube removal after pulmonary lobectomy: a meta-analysis. Interact Cardiovasc Thorac Surg. 2018;27(5):695-702.

　　19、Su C, Shi K, Cheng X, et al. Long Noncoding RNA LINC00472 Inhibits Proliferation and Promotes Apoptosis of Lung Adenocarcinoma Cells via Regulating miR-24-3p/ DEDD. Technol Cancer Res Treat. 2018;17:1533033818790490.

　　20、Su C, Han Y, Zhang H, et al. CiRS-7 targeting miR-7 modulates the progression of non-small cell lung cancer in a manner dependent on NF-κB signalling. J Cell Mol Med. 2018;22(6):3097-3107.

　　21、Su C, Cheng X, Li Y, et al. MiR-21 improves invasion and migration of drug-resistant lung adenocarcinoma cancer cell and transformation of EMT through targeting HBP1. Cancer Med. 2018;7(6):2485-2503.

　　22、宋小运,韩毅,杨威,刘志东.肺切除合并上腔静脉系统血管切除治疗局部晚期肺癌可行性分析[J].中华肿瘤防治杂志,2018,25(06):408-410.

　　23、李云松,刘毅,刘志东.临床医学专业研究生转化研究和教育中面临的问题探讨[J].基础医学教育,2018,20(02):126-128.

　　24、Zhang T, Guo Q, Zhang Y, Liu Z, Zhou S, Xu S. Meta-analysis of adjuvant chemotherapy versus surgery alone in T2aN0 stage IB non-small cell lung cancer. J Cancer Res Ther. 2018;14(1):139-144.

　　25、段新春,刘志东,许绍发.循环肿瘤细胞在早期肺癌诊疗中的研究进展[J].中国肺癌杂志,2017,20(10):703-709.

　　26、Yu DP, Cheng X, Liu ZD, Xu SF. Comparative beneficiary effects of immunotherapy against chemotherapy in patients with advanced NSCLC: Meta-analysis and systematic review. Oncol Lett. 2017;14(2):1568-1580.

　　27、Li Y, Cheng X, Chen Z, Liu Y, Liu Z, Xu S. Circulating tumor cells in peripheral and pulmonary venous blood predict poor long-term survival in resected non-small cell lung cancer patients. Sci Rep. 2017;7(1):4971. Published 2017 Jul 10.

　　28、Che NY, Huang SJ, Ma Y, et al. Comparison of Histological, Microbiological, and Molecular Methods in Diagnosis of Patients with TBLN Having Different Anti-TB Treatment Background. Biomed Environ Sci. 2017;30(6):418-425.

　　29、Huang SJ, Wang XH, Liu ZD, et al. Vitamin D deficiency and the risk of tuberculosis: a meta-analysis. Drug Des Devel Ther. 2016;11:91-102. Published 2016 Dec 28.

　　30、Han Y, Su C, Yu D, et al. Cholecystokinin attenuates radiation-induced lung cancer cell apoptosis by modulating p53 gene transcription. Am J Transl Res. 2017;9(2):638-646. Published 2017 Feb 15.

　　31、Chen S, Han Y, Yu D, et al. Transdermal delivery of isoniazid and rifampin in guinea pigs by electro-phonophoresis. Drug Deliv. 2017;24(1):467-470.